|
Autismus
|
CBD, THC
|
Children with ASD have been found to possess lower-than-normal levels of certain endogenous cannabinoids, including anandamide.
|
2019
|
|
Autismus
|
CBD, THC
|
Human studies and case reports have documented improvements in ASD patients following the administration of various cannabinoid formulations.
|
2022
|
|
Kopfschmerzen/Migräne
|
THC
|
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population
|
2016
|
|
Chronische Schmerzen
|
CBD
|
Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study
|
2019
|
|
Chronische Schmerzen
|
CBD, THC
|
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion
|
2004
|
|
Chronische Schmerzen
|
CBD
|
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
|
2003
|
|
Ängste
|
CBD
|
Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report
|
2016
|
|
Ängste
|
CBD
|
Effects of cannabidiol (CBD) on regional cerebral blood flow
|
2004
|
|
Ängste
|
CBD
|
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients
|
2011
|
|
Ängste
|
CBD
|
Cannabidiol in Anxiety and Sleep: A Large Case Series
|
2019
|
|
Epilepsie
|
CBD
|
Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox-Gastaut syndrome (LGS)
|
2017
|
|
Epilepsie
|
CBD
|
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
|
2017
|
|
Schlafstörungen
|
CBD
|
Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report
|
2016
|
|
Schlafstörungen
|
CBD
|
Cannabidiol in Anxiety and Sleep: A Large Case Series
|
2019
|
|
Kopfschmerzen/Migräne
|
CBD
|
Survey Shows CBD Has Positive Impact on Migraines
|
2020
|
|
Chronische Schmerzen
|
CBD, THC
|
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
|
2011
|
|
Autismus
|
CBD
|
Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
|
2019
|
|
Ängste
|
CBD
|
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|
2010
|
|
Autismus
|
CBD, THC
|
Modulation of the endocannabinoid system has been suggested as a target for ASD therapies
|
2017
|
|
Autismus
|
THC
|
150 adolescents with autism. decrease disruptive behaviors associated with ASD
|
2021
|
|
Autismus
|
CBD, THC
|
A 15-year-old patient with autism after adding low doses of CBD/THC extracts adjunctively. Improved within six months
|
2021
|
|
Autismus
|
THC
|
Children and young adults with ASD consumed either cannabis or hemp-based products. reported 60-91 percent improvements
|
2020
|
|
Autismus
|
CBD
|
CBD extracts resulted in “overall improvements” in a cohort of 53 children with ASD.
|
2018
|
|
Autismus
|
CBD
|
CBD-dominant cannabis extracts led to significant improvements in over 60 percent of ASD patients with refractory behavioral problems.
|
2018
|
|
Autismus
|
CBD
|
CBD extracts was associated with improved ASD symptoms in 14 out of 15 adolescent subjects
|
2019
|
|
ADHS
|
CBD
|
Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report
|
2016
|
|
Arthritis
|
CBD, THC
|
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
|
2005
|
|
Arthritis
|
CBD
|
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
|
2016
|
|
Autismus
|
THC
|
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
|
2018
|
|
Autismus
|
CBD
|
Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study
|
2022
|
|
Autismus
|
CBD
|
Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial
|
2022
|
|
Arthritis
|
CBD, THC
|
Cannabinoids and the immune system: potential for the treatment of inflammatory diseases
|
2005
|
|
Arthritis
|
CBD, THC
|
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis
|
2015
|
|
Arthritis
|
CBD, THC
|
The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis
|
2020
|
|
Arthritis
|
CBD, THC
|
Preliminary assessment of the efficacy, tolerability and safety of a cannabis medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
|
2006
|
|
Arthritis
|
CBD, THC
|
Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases: A systematic review of randomized controlled trials
|
2016
|
|
Arthritis
|
CBD, THC
|
Are cannabis, cannabis-derived products, and synthetic cannabinoids a therapeutic tool for rheumatoid arthritis? A friendly summary of the evidence
|
2021
|
|
Arthritis
|
THC
|
Survey of Australians using cannabis for medical purposes
|
2005
|
|
Arthritis
|
THC
|
The medicinal use of cannabis in the UK: results of a nationwide survey
|
2005
|
|
Arthritis
|
THC
|
Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington state
|
2009
|
|
Arthritis
|
THC
|
Cannabis use assessment and its impact on pain in rheumatologic diseases: A systematic review and meta-analysis
|
2020
|
|
Stress/PTBS
|
THC
|
Cannabis use and post-traumatic stress disorder: prospective evidence from a longitudinal study of veterans
|
2020
|
|
Stress/PTBS
|
THC
|
The Long-Term, Prospective, Therapeutic Impact of cannabis on Post-Traumatic Stress Disorder
|
2020
|
|
Stress/PTBS
|
THC
|
Effects of Delta-9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies
|
2020
|
|
Stress/PTBS
|
CBD, THC
|
Use of cannabinoids for the treatment of patients with post-traumatic stress disorder
|
2021
|
|
Stress/PTBS
|
THC
|
The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial
|
2021
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
The endocannabinoid system and its role in eczematous dermatoses
|
2017
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
Therapeutic and cosmetic uses of cannabis: Cannabinoids for acne treatment and skin rejuvenation
|
2021
|
|
Stress/PTBS
|
THC
|
Impact of cannabis on non-medical opioid-use and symptoms of post-traumatic stress disorder: A nationwide longitudinal VA study
|
2020
|
|
Stress/PTBS
|
THC
|
Short and long-term effects of cannabis on symptoms of post-traumatic stress disorder
|
2020
|
|
Stress/PTBS
|
THC
|
Impact of Cannabis Use on Treatment Outcomes among Adults Receiving Cognitive-Behavioral Treatment for PTSD and Substance Use Disorders
|
2017
|
|
Stress/PTBS
|
THC
|
Mental health symptom severity in cannabis using and non-using Veterans with probable PTSD
|
2016
|
|
Stress/PTBS
|
THC
|
“Medical marijuana may worsen PTSD symptoms, increase violence.”
|
2004
|
|
Stress/PTBS
|
THC
|
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program
|
2014
|
|
Stress/PTBS
|
THC
|
Preliminary, open-label, pilot study of add-on oral delta-9-tetrahydrocannabinol in chronic post-traumatic stress disorder
|
2014
|
|
Stress/PTBS
|
CBD, THC
|
The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)
|
2009
|
|
Stress/PTBS
|
CBD, THC
|
Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation
|
2014
|
|
Stress/PTBS
|
CBD, THC
|
Cannabinoid modulation of fear extinction brain circuits: a novel target to advance anxiety treatment
|
2014
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
Cannabinoids may soothe certain skin diseases, say researchers
|
2017
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: A report of three cases
|
2019
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
The role of cannabinoids in dermatology
|
2017
|
|
Arthritis
|
CBD
|
Cannabidiol: A killer for inflammatory rheumatoid arthritis synovial fibroblasts
|
2020
|
|
Arthritis
|
CBD
|
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine
|
2000
|
|
Arthritis
|
CBD, THC
|
Comparative in silico analyses of Cannabis sativa, Prunella vulgaris and Withania somnifera compounds elucidating the medicinal properties against rheumatoid arthritis
|
2017
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
Frontiers in pruritus research: scratching the brain for more effective itch therapy
|
2006
|
|
Hautausschläge/Hautreizungen
|
THC
|
Cannabis use for restless legs syndrome and uremic pruritus in patients with maintenance dialysis: A survey
|
2020
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
The potential role of cannabinoids in dermatology
|
2020
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: a case report
|
2021
|
|
Hautausschläge/Hautreizungen
|
THC
|
Treatment of chronic pruritus with medical marijuana
|
2021
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
Efficacy and tolerance of the cream containing structured physiological lipid endocannabinoids in the treatment of uremic pruritus: a preliminary study
|
2005
|
|
Hautausschläge/Hautreizungen
|
CBD
|
Therapeutic potential of cannabidiol for skin health and disorders
|
2020
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
Cannabinoids in dermatology: Hope or hype?
|
2020
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
Cannabinoids in dermatology: A scoping review
|
2018
|
|
Hautausschläge/Hautreizungen
|
THC
|
Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease
|
2002
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin (PDF)
|
2003
|
|
Hautausschläge/Hautreizungen
|
CBD, THC
|
Cannabinoid agonists attenuate capsaicin-induced responses in human skin
|
2003
|
|
Hautausschläge/Hautreizungen
|
CBD
|
Self-initiated use of topical cannabidiol oil for epidermolysis bullosa
|
2018
|
|
Multiple Sklerose
|
CBD, THC
|
Cannabisnoid use among Americans with MS: Current trends and gaps in knowledge
|
2020
|
|
Multiple Sklerose
|
THC
|
Multiple Sclerosis and use of medical cannabis: A retrospective review evaluating symptom outcomes
|
2019
|
|
Multiple Sklerose
|
THC
|
Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A Web-based investigation
|
2017
|
|
Multiple Sklerose
|
CBD, THC
|
Efficacy and tolerability of phytomedicines in multiple sclerosis patients: A review
|
2017
|
|
Multiple Sklerose
|
THC
|
Cannabis use in patients with multiple sclerosis
|
2006
|
|
Multiple Sklerose
|
THC
|
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
|
2005
|
|
Multiple Sklerose
|
THC
|
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
|
2004
|
|
Multiple Sklerose
|
THC
|
An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis
|
2004
|
|
Multiple Sklerose
|
THC
|
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis
|
2016
|
|
Multiple Sklerose
|
THC
|
Cannabis and multiple sclerosis: The way forward
|
2017
|
|
Kopfschmerzen/Migräne
|
THC
|
Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users
|
2021
|
|
Kopfschmerzen/Migräne
|
THC
|
Effects of medical marijuana on migraine headache frequency in an adult population
|
2016
|
|
Kopfschmerzen/Migräne
|
CBD, THC
|
Cannabinoids suitable for migraine prevention.
|
2017
|
|
Kopfschmerzen/Migräne
|
THC
|
Short- and Long-Term Efects of Cannabis on Headache and Migraine
|
2019
|
|
Kopfschmerzen/Migräne
|
THC
|
Migraine frequency decrease following prolonged medical cannabis treatment: A cross-sectional study
|
2020
|
|
Kopfschmerzen/Migräne
|
THC
|
“Marijuana for Migraine? Some Tentative Evidence.”
|
2020
|
|
Kopfschmerzen/Migräne
|
THC
|
Alleviative effects of cannabis flower on migraine and headache
|
2020
|
|
Kopfschmerzen/Migräne
|
THC
|
Efficacy and safety of medical marijuana in migraine headache: A systematic review
|
2022
|
|
Multiple Sklerose
|
THC
|
Patterns of cannabis use among patients with multiple sclerosis
|
2004
|
|
Multiple Sklerose
|
THC
|
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study
|
2004
|
|
Multiple Sklerose
|
CBD, THC
|
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis: multicentre randomized placebo-controlled trial
|
2003
|
|
Multiple Sklerose
|
THC
|
Cannabis use as described by people with multiple sclerosis [PDF]
|
2003
|
|
Multiple Sklerose
|
THC
|
Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms of multiple sclerosis
|
2006
|
|
Multiple Sklerose
|
THC
|
Oromucosal delta-9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial
|
2007
|
|
Multiple Sklerose
|
THC
|
The use of medical-grade cannabis in patients non-responders to nabiximols.
|
2016
|
|
Stress/PTBS
|
THC
|
Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians
|
2019
|
|
Stress/PTBS
|
CBD, THC
|
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
|
2013
|
|
Stress/PTBS
|
THC
|
Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence
|
2012
|
|
Stress/PTBS
|
CBD, THC
|
Cannabinoid facilitation of fear extinction memory recall in humans
|
2012
|
|
Multiple Sklerose
|
THC
|
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
|
2012
|
|
Multiple Sklerose
|
CBD, THC
|
Neuroprotection in experimental autoimmune encephalomyelitis and progressive multiple sclerosis by cannabis-based cannabinoids
|
2015
|
|
Multiple Sklerose
|
CBD, THC
|
Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis
|
2003
|
|
Multiple Sklerose
|
CBD, THC
|
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB(1) receptor-mediated anti-inflammatory effects
|
2012
|
|
Multiple Sklerose
|
CBD, THC
|
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
|
2003
|
|
Multiple Sklerose
|
THC
|
The perceived effects of smoked cannabis on patients with multiple sclerosis
|
1997
|
|
Multiple Sklerose
|
CBD, THC
|
Effects of cannabinoids on spasticity and ataxia in multiple sclerosis
|
1989
|
|
Multiple Sklerose
|
THC
|
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis
|
1987
|
|
Multiple Sklerose
|
THC
|
Marijuana as a therapeutic agent for muscle spasm or spasticity
|
1980
|
|
Multiple Sklerose
|
CBD, THC
|
THC:CBD observational study data: Evolution of resistant MS spasticity and associated symptoms
|
2016
|
|
Multiple Sklerose
|
THC
|
Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis
|
2021
|
|
Multiple Sklerose
|
CBD, THC
|
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
|
2003
|
|
Hypertonie
|
CBD, THC
|
Endocannabinoids as cardiovascular modulators
|
2000
|
|
Hypertonie
|
THC
|
Cardiovascular system effects of marijuana
|
2002
|
|
Hypertonie
|
CBD, THC
|
Cardiac and vascular effects of cannabinoids: toward a therapeutic use?
|
2005
|
|
Hypertonie
|
THC
|
Cannabis and cardiotoxicity
|
2006
|
|
Hypertonie
|
THC
|
Marijuana use, diet, body mass index and cardiovascular risk factors
|
2006
|
|
Hypertonie
|
THC
|
A systemic review and meta-analysis of randomized controlled trials for cardiovascular toxicity of medical cannabinoids
|
2021
|
|
Hypertonie
|
CBD, THC
|
Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis
|
2006
|
|
Hypertonie
|
CBD, THC
|
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
|
2005
|
|
Hypertonie
|
CBD, THC
|
Endocannabinoids and vascular function
|
2000
|
|
Hypertonie
|
CBD, THC
|
Blood pressure regulation by endocannabinoids and their receptors
|
2005
|
|
|
THC
|
Association between cannabis use and the risk of bladder cancer: Results from the California Men’s Health Study
|
2015
|
|
|
CBD, THC
|
The use of cannabinoids as anticancer agents
|
2015
|
|
|
CBD, THC
|
Cannabinoids and cancer
|
2005
|
|
|
CBD, THC
|
Cannabinoids for cancer treatment: progress and promise
|
2008
|
|
|
THC
|
Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use
|
2017
|
|
|
THC
|
Integrating cannabis into clinical care
|
2016
|
|
Hypertonie
|
CBD, THC
|
Clinical pharmacodynamics of cannabinoids
|
2006
|
|
Hypertonie
|
CBD, THC
|
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
|
2004
|
|
Hypertonie
|
THC
|
Lifetime marijuana use and subclinical atherosclerosis: The Coronary Artery Risk Development in Young Adults (CARDIA) study
|
2018
|
|
Hypertonie
|
CBD, THC
|
Cannabinoid receptors in atherosclerosis
|
2006
|
|
Hypertonie
|
THC
|
Association between marijuana use and cardiovascular disease in US adults
|
2021
|
|
Kopfschmerzen/Migräne
|
CBD, THC
|
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels
|
2008
|
|
Kopfschmerzen/Migräne
|
THC
|
Hemp for Headache: An In-Depth Historical and Scientific Review of Cannabis in Migraine Treatment
|
2001
|
|
Kopfschmerzen/Migräne
|
CBD, THC
|
Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache
|
2015
|
|
Kopfschmerzen/Migräne
|
THC
|
The use of cannabis for headache disorders
|
2017
|
|
Kopfschmerzen/Migräne
|
CBD, THC
|
Cannabinoid use in a tertiary headache clinic: A cross-sectional survey
|
2022
|
|
Kopfschmerzen/Migräne
|
THC
|
30% of Migraine Sufferers in American Have Tried Cannabis For Migraine Relief.
|
2020
|
|
Kopfschmerzen/Migräne
|
THC
|
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep
|
2017
|
|
Kopfschmerzen/Migräne
|
THC
|
A cross-sectional survey of medical cannabis users: Patterns of use and perceived efficacy
|
2017
|
|
Kopfschmerzen/Migräne
|
CBD, THC
|
Degradation of endocannabinoids in chronic migraine and medication overuse headache
|
2008
|
|
Kopfschmerzen/Migräne
|
CBD, THC
|
Endocannabinoids in chronic migraine: CSF findings suggest a system failure
|
2007
|
|
Hypertonie
|
THC
|
Association of Marijuana Use and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System Data Analysis of 133,706 US Adults
|
2020
|
|
Hypertonie
|
THC
|
Cannabis is associated with blood pressure reduction in older adults: A 24-hours ambulatory blood pressure monitoring study
|
2021
|
|
Hypertonie
|
THC
|
Cardiovascular Effects of Medical Marijuana: A Systemic Review
|
2021
|
|
Hypertonie
|
THC
|
Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know
|
2014
|
|
Kopfschmerzen/Migräne
|
CBD, THC
|
Clinical Endocannbinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistent Syndromes
|
2016
|
|
Kopfschmerzen/Migräne
|
THC
|
Benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
|
2004
|
|
Kopfschmerzen/Migräne
|
CBD, THC
|
The endocannabinoid system and migraine
|
2010
|
|
Kopfschmerzen/Migräne
|
CBD, THC
|
Abnormal degradation of endocannabinoids in migrainous women
|
2003
|
|
|
CBD
|
Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules
|
2013
|
|
|
THC
|
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns
|
2016
|
|
|
CBD, THC
|
Cannabinoids: potential anticancer agents (PDF)
|
2003
|
|
|
CBD
|
Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival
|
2010
|
|
|
THC
|
Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo
|
2008
|
|
|
THC
|
Enhancing the in vitro cytotoxic activity of Delta9-tetrahydrocannabinol in leukemic cells through a combinatorial approach
|
2008
|
|
|
THC
|
Delta-9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemic T cells is regulated by translocation of Bad to mitochondria
|
2006
|
|
|
THC
|
Cannabis-induced cytotoxicity in leukemic cell lines
|
2005
|
|
|
CBD, THC
|
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
|
2003
|
|
|
CBD
|
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
|
2012
|
|
|
CBD, THC
|
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase-2
|
2005
|
|
|
CBD
|
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
|
2013
|
|
|
CBD
|
Cannabinoids: potential anticancer agents
|
2003
|
|
|
CBD, THC
|
Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells
|
1998
|
|
|
THC
|
“Study finds no cancer-marijuana connection.”
|
2006
|
|
|
THC
|
Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation
|
2013
|
|
|
CBD, THC
|
Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation
|
2008
|
|
|
CBD
|
Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma
|
2006
|
|
|
CBD
|
Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers
|
2017
|
|
|
THC
|
The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration
|
2010
|
|
|
CBD, THC
|
Cannabinoids inhibit cellular respiration of human oral cancer cells
|
2010
|
|
|
CBD
|
Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells
|
2016
|
|
|
CBD, THC
|
Inhibition of cancer cell invasion by cannabinoids via increased cell expression of tissue inhibitor of matrix metalloproteinases-1
|
2008
|
|
|
CBD, THC
|
Cannabinoids in pancreatic cancer: correlation with survival and pain
|
2008
|
|
|
CBD, THC
|
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes
|
2006
|
|
|
THC
|
A population-based case-control study of marijuana use and head and neck squamous cell carcinoma
|
2009
|
|
|
CBD, THC
|
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications
|
2012
|
|
|
THC
|
Delta-9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism
|
1999
|
|
|
CBD, THC
|
Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines
|
2003
|
|
|
CBD, THC
|
Cannabinoid receptors as a novel target for the treatment of prostate cancer
|
2005
|
|
|
CBD, THC
|
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
|
2010
|
|
Magen-Darm-Beschwerden
|
THC
|
Treatment of Crohn’s disease with cannabis: an observational study
|
2011
|
|
Magen-Darm-Beschwerden
|
THC
|
Association between cannabis use and complications related to Crohn’s disease: A retrospective cohort study
|
2019
|
|
Magen-Darm-Beschwerden
|
THC
|
Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study
|
2013
|
|
Magen-Darm-Beschwerden
|
THC
|
Low-dose cannabidiol is safe but not effective in the treatment for Crohn’s disease, a randomized controlled trial
|
2017
|
|
Magen-Darm-Beschwerden
|
CBD, THC
|
Cannabinoids and the digestive tract
|
2005
|
|
Magen-Darm-Beschwerden
|
CBD
|
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
|
2009
|
|
|
THC
|
Delta-9-tetrahydrocannabinol induces apoptosis in C6 glioma cells
|
1998
|
|
|
CBD, THC
|
Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
|
2000
|
|
Magen-Darm-Beschwerden
|
THC
|
Medical cannabis for inflammatory bowel disease: Real-life experience of mode of consumption and assessment of side effects
|
2019
|
|
Magen-Darm-Beschwerden
|
THC
|
Association between cannabis use and healthcare utilization in patients with irritable bowel syndrome: A retrospective cohort study
|
2020
|
|
Magen-Darm-Beschwerden
|
THC
|
Therapeutic use of cannabis in Inflammatory Bowel Disease
|
2016
|
|
Magen-Darm-Beschwerden
|
THC
|
Cannabis for inflammatory bowel disease
|
2014
|
|
Magen-Darm-Beschwerden
|
CBD, THC
|
Cannabinoids and bladder symptoms in multiple sclerosis
|
2021
|
|
Magen-Darm-Beschwerden
|
THC
|
Nabilone administration in refractory chronic diarrhea: A case series
|
2019
|
|
Magen-Darm-Beschwerden
|
THC
|
Illicit cannabis use as a management strategy in New Zealand women with endometriosis
|
2020
|
|
Magen-Darm-Beschwerden
|
CBD, THC
|
Impact of cannabinoids on symptoms of refractory gastroparesis: A single-center experience
|
2019
|
|
Magen-Darm-Beschwerden
|
THC
|
Association between cannabis use and complications related to ulcerative colitis in hospitalized patients
|
2019
|
|
Magen-Darm-Beschwerden
|
CBD, THC
|
Cannabinoids improve gastrointestinal symptoms in a parenteral nutrition–dependent patient with chronic intestinal pseudo-obstruction
|
2020
|
|
|
CBD, THC
|
Inhibition of tumor angiogenesis by cannabinoids
|
2003
|
|
|
CBD
|
Antitumor Effects of Cannabidiol, a Nonpsychotropic Cannabinoid, on Human Glioma Cell Lines
|
2004
|
|
|
CBD, THC
|
Cannabinoids inhibit the vascular endothelial growth factor pathways in gliomas (PDF)
|
2004
|
|
|
CBD
|
Concomitant treatment of malignant brain tumors with CBD: A case series and review of the literature
|
2019
|
|
|
THC
|
A phase II randomized clinical trial assessing the tolerability of two different ratios of medicinal cannabis in patients with high grade gliomas
|
2021
|
|
|
THC
|
Cannabis use in palliative oncology: A review of the evidence for popular indications
|
2017
|
|
|
CBD
|
Cannabidiol–from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer
|
2019
|
|
|
THC
|
Delta-9-Tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation
|
2006
|
|
|
CBD
|
Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
|
2006
|
|
|
CBD, THC
|
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
|
1998
|
|
|
CBD
|
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
|
2007
|
|
|
CBD
|
Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol
|
2019
|
|
|
CBD
|
Report of objective clinical responses of cancer patients to pharmaceutical-grade synthetic cannabidiol
|
2018
|
|
|
CBD, THC
|
Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells
|
2005
|
|
|
CBD, THC
|
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
|
2011
|
|
|
THC
|
A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
|
2006
|
|
|
CBD, THC
|
Cannabinoids as a potential new drug therapy for the treatment of gliomas
|
2008
|
|
|
THC
|
Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells
|
2007
|
|
|
CBD, THC
|
Expression of cannabinoid receptors and neurotrophins in human gliomas
|
2007
|
|
|
CBD, THC
|
GW Pharmaceuticals achieves positive results in Phase 2 proof of concept study in glioma
|
2017
|
|
|
THC
|
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas–possible role of cannabis inhalation
|
2011
|
|
Fibromyalgie
|
THC
|
Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief
|
2006
|
|
Fibromyalgie
|
THC
|
Nabilone for the treatment of pain in fibromyalgia.
|
2008
|
|
Fibromyalgie
|
THC
|
The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial.
|
2010
|
|
Fibromyalgie
|
THC
|
Cannabis use in patients with fibromyalgia: Effect on symptoms relief and health-related quality of life.
|
2011
|
|
Fibromyalgie
|
THC
|
Medical cannabis for the treatment of fibromyalgia.
|
2018
|
|
Fibromyalgie
|
THC
|
Effect of adding medical cannabis treatment to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study.
|
2018
|
|
Fibromyalgie
|
THC
|
Safety and efficacy of medical cannabis in fibromyalgia.
|
2019
|
|
Fibromyalgie
|
THC
|
Characteristics of medical cannabis usage among patients with fibromyalgia.
|
2020
|
|
Fibromyalgie
|
THC
|
Migraine, fibromyalgia, irritable bowel, and other treatment-resistent syndromes
|
2016
|
|
Fibromyalgie
|
THC
|
Therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
|
2014
|
|
Fibromyalgie
|
THC
|
Medical cannabis in Arizona: Patient characteristics, perceptions, and impressions of medical cannabis legalization
|
2015
|
|
Fibromyalgie
|
THC
|
The consumption of cannabis by fibromyalgia patients in Israel.
|
2018
|
|
Fibromyalgie
|
THC
|
Cannabis use among patients in a large US rheumatic disease registry.
|
2019
|
|
Fibromyalgie
|
THC
|
Cannabidiol use for fibromyalgia: Prevalence of use and perception of effectiveness in a large online survey.
|
2021
|
|
Fibromyalgie
|
THC
|
Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalization: A cross-sectional study.
|
2021
|
|
Fibromyalgie
|
THC
|
Cannabis use assessment and its impact on pain in rheumatologic disease: A systematic review and meta-analysis.
|
2021
|
|
Fibromyalgie
|
THC
|
The Effect of Medical Cannabis on Pain Level and Quality of Sleep among Rheumatology Clinic Outpatients.
|
2021
|
|
Fibromyalgie
|
THC
|
Therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
|
2004
|
|
Fibromyalgie
|
THC
|
Adding medical cannabis to standard analgesic treatment for fibromyalgia: A prospective observational trial.
|
2020
|
|
Fibromyalgie
|
THC
|
Ingestion of THC-rich cannabis oil in people with fibromyalgia: A randomized, double-blind, placebo-controlled clinical trial.
|
2020
|
|
Fibromyalgie
|
THC
|
Medical cannabis for the treatment of fibromyalgia syndrome: A retrospective, open-label case series.
|
2021
|
|
Magen-Darm-Beschwerden
|
THC
|
Cannabis use among patients with inflammatory bowel disease
|
2011
|
|
Magen-Darm-Beschwerden
|
THC
|
Marijuana use patterns among patients with inflammatory bowel disease
|
2013
|
|
Magen-Darm-Beschwerden
|
CBD, THC
|
Endocannabinoids and the gastrointestinal tract
|
2006
|
|
Magen-Darm-Beschwerden
|
CBD, THC
|
Cannabinoids and the gastrointestinal tract
|
2001
|
|
Magen-Darm-Beschwerden
|
CBD, THC
|
Cannabinoids for gastrointestinal diseases: potential therapeutic applications
|
2003
|
|
Magen-Darm-Beschwerden
|
CBD, THC
|
Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs
|
2002
|
|
Magen-Darm-Beschwerden
|
CBD, THC
|
Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing
|
2005
|
|
Magen-Darm-Beschwerden
|
CBD, THC
|
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract
|
2005
|
|
Magen-Darm-Beschwerden
|
THC
|
Cannabinoids for treating inflammatory bowel diseases: Where are we and where do we go?
|
2017
|
|
Magen-Darm-Beschwerden
|
THC
|
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis
|
2015
|
|
Fibromyalgie
|
THC
|
Safety and efficacy of medicinal cannabis in the treatment of fibromyalgia: A systematic review.
|
2021
|
|
Magen-Darm-Beschwerden
|
THC
|
Gastrointestinal illness and cannabis use in a rural Canadian community
|
1984
|
|
Magen-Darm-Beschwerden
|
THC
|
Survey of Australians using cannabis for medical purposes
|
2005
|
|
Magen-Darm-Beschwerden
|
THC
|
Ulcerative colitis and marijuana
|
1990
|
|
Magen-Darm-Beschwerden
|
THC
|
Cannabis alleviates symptoms of Crohn’s Disease
|
2005
|
|
Magen-Darm-Beschwerden
|
THC
|
Preferences for medical marijuana over prescription medications among persons living with chronic conditions
|
2017
|
|
Magen-Darm-Beschwerden
|
THC
|
Drug-herb interactions in the elderly patient with IBD: A growing concern
|
2017
|
|
Magen-Darm-Beschwerden
|
THC
|
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease
|
2014
|
|
Diabetes
|
THC
|
Estimating the Relationship between Marijuana Use and Body Mass Index
|
2016
|
|
Diabetes
|
THC
|
Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data
|
2016
|
|
Diabetes
|
THC
|
Metabolic syndrome in people with a psychotic illness: is cannabis protective?
|
2016
|
|
Diabetes
|
THC
|
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study
|
2017
|
|
Diabetes
|
THC
|
Obesity and cannabis use: results from 2 representative national surveys
|
2011
|
|
Epilepsie
|
THC
|
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit
|
2016
|
|
Epilepsie
|
THC
|
Marijuana use among patients with epilepsy at a tertiary care center
|
2019
|
|
Diabetes
|
THC
|
Cannabis use in relation to obesity and insulin resistance in the inuit population
|
2015
|
|
Diabetes
|
THC
|
Marijuana use on glucose, insulin, and insulin resistance among US adults
|
2013
|
|
Diabetes
|
THC
|
Decreased prevalence of diabetes in marijuana users
|
2012
|
|
Diabetes
|
CBD, THC
|
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes
|
2017
|
|
Diabetes
|
THC
|
Efficacy of inhaled cannabis on painful diabetic neuropathy
|
2015
|
|
Diabetes
|
CBD
|
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy
|
2010
|
|
Diabetes
|
CBD, THC
|
The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats
|
2004
|
|
Diabetes
|
CBD, THC
|
Cannabinoids block tactile allodynia in diabetic mice without attenuation of its antinociceptive effect
|
2004
|
|
Epilepsie
|
CBD
|
Results of Epidiolex Trial in Lennox-Gastaut Syndrone announced
|
2016
|
|
Epilepsie
|
THC
|
Marijuana stops child’s severe seizures
|
2013
|
|
Epilepsie
|
CBD
|
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
|
2013
|
|
Epilepsie
|
CBD
|
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome
|
2015
|
|
Fibromyalgie
|
THC
|
The medicinal use of cannabis in the UK: results of a nationwide survey
|
2005
|
|
Fibromyalgie
|
THC
|
Survey of Australians using cannabis for medical purposes
|
2005
|
|
Epilepsie
|
CBD
|
Long-term safety and efficacy of highly purified cannabidiol for treatment of refractory epilepsy.
|
2021
|
|
Epilepsie
|
CBD
|
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment resistant epilepsy.
|
2020
|
|
Epilepsie
|
CBD
|
Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy.
|
2015
|
|
Epilepsie
|
CBD, THC
|
A prospective open-label trial of a CBD/THC cannabis oil in Dravet syndrome.
|
2018
|
|
Epilepsie
|
CBD
|
Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
|
2016
|
|
Epilepsie
|
CBD
|
Cannabidiol as a potential treatment for febrile infection-related epilepsy syndrome (FIRES) in the acute and chronic phases
|
2016
|
|
Fibromyalgie
|
THC
|
Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia
|
2012
|
|
Epilepsie
|
CBD, THC
|
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
|
2015
|
|
Epilepsie
|
CBD
|
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience
|
2016
|
|
Epilepsie
|
CBD, THC
|
Medical marijuana liquid extract may bring hope for children with severe epilepsy
|
2015
|
|
Epilepsie
|
THC
|
Marijuana chemical shows promise for hard-to-treat epilepsy in kids
|
2015
|
|
Epilepsie
|
CBD
|
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
|
2015
|
|
Epilepsie
|
THC
|
Does medical marijuana oil work? UAB shares insight into Carly’s Law study
|
2016
|
|
Autismus
|
THC
|
Real life experiences of medical cannabis treatment in autism: Analysis of safety and efficacy
|
2019
|
|
Autismus
|
CBD
|
Oral cannabidiol use in children in with autism spectrum disorder to treat related symptoms and co-morbidities
|
2019
|
|
Autismus
|
THC
|
Autism spectrum disorder and medical cannabis: Review and clinical experience
|
2020
|
|
Autismus
|
CBD, THC
|
A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extract as complementary therapy: A case report
|
2021
|
|
Autismus
|
CBD
|
CBD-enriched cannabis for autism spectrum disorder: An experience of a single center in Turkey and reviews of the literature
|
2021
|
|
Autismus
|
CBD, THC
|
Cannabinoid treatment for autism: A proof-of-concept randomized trials
|
2021
|
|
Autismus
|
CBD
|
Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: Randomized, double-blind and controlled placebo clinical trial
|
2022
|
|
Autismus
|
CBD
|
Cannabidiol-based medical cannabis in children with autism: A retrospective feasibility study
|
2018
|
|
Autismus
|
CBD
|
Effects of CBD-enriched cannabis sativa extract on autism spectrum disorder symptoms: An observational study of 18 participants undergoing compassionate use
|
2019
|
|
Autismus
|
CBD, THC
|
Cannabis and cannabinoid use in autism spectrum disorder: A systematic review
|
2021
|
|
Autismus
|
CBD, THC
|
Melbourne study explores medicinal cannabis as a treatment for children with autism
|
|
|
Chronische Schmerzen
|
THC
|
Patient-reported outcomes in those consuming medical cannabis: A prospective longitudinal observational study in chronic pain patients
|
2021
|
|
Chronische Schmerzen
|
THC
|
Cannabis significantly reduces the use of prescription opioids and improves quality of life in authorized patients: Results of a large prospective study
|
2021
|
|
Chronische Schmerzen
|
THC
|
Prescribing cannabis for harm reduction
|
2012
|
|
Chronische Schmerzen
|
THC
|
Cannabinergic pain medicine: a concise clinical primer and survey of randomized-controlled trial results
|
2012
|
|
Chronische Schmerzen
|
CBD, THC
|
Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control
|
2020
|
|
Autismus
|
CBD, THC
|
The endocannabinoid system and autism spectrum disorders: Insights from animal models
|
2017
|
|
Autismus
|
CBD, THC
|
Lower circulating endocannabinoid levels in children with autism spectrum disorder
|
2019
|
|
Alzheimer/Demenz
|
CBD, THC
|
Prevention of Alzheimer’s disease pathology by cannabinoids
|
2005
|
|
Alzheimer/Demenz
|
CBD
|
Israeli research shows cannabidiol may slow Alzheimer’s disease
|
2010
|
|
Alzheimer/Demenz
|
THC
|
A molecular link between the active component of marijuana and Alzheimer’s disease pathology
|
2006
|
|
Alzheimer/Demenz
|
THC
|
Safety and efficacy of medical cannabis oil for behavioral and psychological symptom of dementia: An open label, add-on, pilot study
|
2016
|
|
Alzheimer/Demenz
|
CBD, THC
|
Cannabinoids in the management of frontotemporal dementia: A case series
|
2021
|
|
Diabetes
|
THC
|
Cannabis Smoking and Diabetes Mellitus: Results from Meta-Analysis with Eight Independent Replication Samples
|
2015
|
|
Diabetes
|
CBD, THC
|
Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases
|
2005
|
|
Diabetes
|
CBD, THC
|
The cannabinergic system as a target for anti-inflammatory therapies
|
2006
|
|
Diabetes
|
CBD
|
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
|
2006
|
|
Diabetes
|
THC
|
The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
|
2013
|
|
Diabetes
|
CBD
|
Neuroprotective and blood-retinal barrier preserving effects of cannabidiol in experimental diabetes
|
2006
|
|
Alzheimer/Demenz
|
THC
|
Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer’s disease.
|
1997
|
|
Alzheimer/Demenz
|
THC
|
Cannabis lifts Alzheimer’s appetite.
|
2003
|
|
Alzheimer/Demenz
|
CBD, THC
|
Cannabinoids remove plaque-forming Alzheimer’s proteins from brain cells
|
2016
|
|
Alzheimer/Demenz
|
CBD, THC
|
Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation
|
2007
|
|
Alzheimer/Demenz
|
THC
|
Cannabis reverses aging process in the brain, study suggests
|
2017
|
|
Alzheimer/Demenz
|
CBD, THC
|
Cannabidiol and delta-9-tetrahydrocannabinol are neuroprotective antioxidants
|
1998
|
|
Alzheimer/Demenz
|
THC
|
Marijuana chemical tapped to fight strokes.
|
1998
|
|
Alzheimer/Demenz
|
CBD, THC
|
Alzheimer’s disease; taking the edge off with cannabinoids?
|
2007
|
|
Alzheimer/Demenz
|
CBD, THC
|
Emerging promise of cannabinoids for the management of pain and associated neuropathological alterations of Alzheimer’s disease
|
2020
|
|
Alzheimer/Demenz
|
THC
|
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
|
2006
|
|
Chronische Schmerzen
|
THC
|
Efficacy of inhaled cannabis on painful diabetic neuropathy
|
2015
|
|
Chronische Schmerzen
|
THC
|
An exploratory human laboratory experiment evaluating vaporized cannabis in the treatment of neuropathic pain from spinal cord injury and disease
|
2016
|
|
Chronische Schmerzen
|
THC
|
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain
|
2008
|
|
Chronische Schmerzen
|
THC
|
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
|
2010
|
|
Chronische Schmerzen
|
THC
|
The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study
|
2014
|
|
Chronische Schmerzen
|
THC
|
Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial
|
2008
|
|
Chronische Schmerzen
|
THC
|
Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial
|
2007
|
|
Chronische Schmerzen
|
THC
|
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers
|
2013
|
|
Chronische Schmerzen
|
THC
|
Dose-dependent Effects of Smoked Cannabis on Capsaicin-Induced Pain and Hyperalgesia in Healthy Volunteers
|
2007
|
|
Chronische Schmerzen
|
CBD, THC
|
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
|
2017
|
|
Chronische Schmerzen
|
CBD, THC
|
Medicinal uses of marijuana and cannabinoids
|
2017
|
|
Chronische Schmerzen
|
THC
|
Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain
|
2016
|
|
Chronische Schmerzen
|
THC
|
Low-dose vaporized cannabis significantly improves neuropathic pain
|
2013
|
|
Chronische Schmerzen
|
THC
|
The pharmacokinetics, efficacy, and safety of a novel selective-dose inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial
|
2020
|
|
Chronische Schmerzen
|
CBD, THC
|
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety and tolerability of THC: CBD extract in patients with intractable cancer-related pain
|
2009
|
|
Chronische Schmerzen
|
THC
|
Medical cannabis for the treatment of fibromyalgia syndrome: A retrospective, open-label case series
|
2021
|
|
Chronische Schmerzen
|
THC
|
A randomized trial of medical cannabis patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction
|
2021
|
|
Chronische Schmerzen
|
THC
|
Cannabis as a substitute for opioid-based pain medication: Patient self-report
|
2017
|
|
Chronische Schmerzen
|
THC
|
Researchers unlock access to pain relief potential of cannabis
|
2019
|
|
Chronische Schmerzen
|
THC
|
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability
|
2018
|
|
Chronische Schmerzen
|
THC
|
Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory model
|
2021
|
|
Chronische Schmerzen
|
THC
|
Cannabiniod-opioid interaction in chronic pain
|
2011
|
|
Chronische Schmerzen
|
THC
|
Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly
|
2018
|
|
Chronische Schmerzen
|
THC
|
Patterns of Marijuana Use and Health Impact: A Survey Among Older Coloradans
|
2019
|
|
Chronische Schmerzen
|
THC
|
Cannabis for the Management of Pain: Assessment of Safety Study
|
2015
|
|
Chronische Schmerzen
|
THC
|
Clinical outcome data of first cohort of chronic pain patients treated with cannabis-based sublingual oils in the United Kingdom – analysis from the UK Medical Cannabis Registry
|
2021
|
|
Chronische Schmerzen
|
THC
|
Multiple Sclerosis and use of medical cannabis: A retrospective review evaluating symptom outcomes
|
2019
|
